Role of Inflammation in Vascular Phenotype Associated with E-cigarette Use

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

October 31, 2026

Conditions

Electronic Cigarette UseEndothelial DysfunctionInflammation

Interventions

DRUG

Placebo

Oral placebo tablet

DRUG

Salsalate 750 MG Oral Tablet [DISALCID]

Oral salsalate tablet

Trial Locations (2)

RECRUITING

Iowa Bioscience Innovation Facility, Iowa City

RECRUITING

University of Iowa, Iowa City

All Listed Sponsors

lead

University of Iowa

OTHER